If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Nov 2020 07:00

RNS Number : 6500F
InnovaDerma PLC
18 November 2020
 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Appointment of Chief Executive Officer

InnovaDerma (LSE: IDP), a leading developer of beauty, personal care and life science products, is pleased to announce that Blake Hughes has been appointed Chief Executive Officer ("CEO") of the Group with immediate effect. He will be based in the UK.

Blake has spent his career in the beauty and personal care sectors and brings with him extensive marketing and digital analytics experience. Most recently, he held the roles of CEO and Chief Marketing Officer of Philip Kingsley, the award-winning premium hair care range. During his tenure at Philip Kingsley, he defined its brand strategy, transformed its eCommerce platform, created a structured product innovation pipeline and step changed international distribution.

Prior to joining Philip Kingsley, Blake was Managing Director, Europe and Africa, of Murad, the prestigious skin care brand. He successfully transformed the business model of this former UK distribution only joint venture into a profitable regional headquarter that managed the distribution of Murad into Europe, Middle East and Africa.

Blake has also worked in a variety of brand and marketing roles for blue chip companies including Procter & Gamble, Elizabeth Arden and Marks & Spencer. He holds a Masters in Chemistry from Oxford University.

 

Joe Bayer will step down as Interim CEO with immediate effect. He will remain as Executive Chairman to support Blake and ensure a smooth handover of the CEO function. Joe intends to step back to Non-executive Chairman after the transition has been completed.

 

Executive Chairman, Joe Bayer, said:

"After an extensive search process, I am very pleased to announce that Blake Hughes has agreed to assume the role of CEO at InnovaDerma. His impressive leadership record and proven ability to generate topline revenue growth whilst improving margins at both blue chip companies and smaller businesses, together with his sector knowledge of the personal care and beauty business, makes him the ideal candidate to lead InnovaDerma. I look forward to working with him as we continue to expand our digital platform and retail network globally."

 

Blake Hughes said:

"I am really excited to be joining InnovaDerma as its new CEO, it's a business with an impressive stable of strong, digitally focused brands which I have long admired. 

 

"I passionately believe in the company's potential to deliver strong financial growth by continuing to build a sustainable digital competitive advantage, drive brand innovation and create exceptional brand experiences for more consumers around the world. InnovaDerma has significant expansion potential and I am proud to join them at this exciting stage of their development."

 

There is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Blake Hughes' appointment.

 

 

Further enquiries

 

InnovaDerma

Joe Bayer

 

 

+61 417 870 743

 

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFWEFWESSEDF
Date   Source Headline
9th Oct 20195:14 pmRNSNotice of AGM & Annual Report
24th Sep 20197:00 amRNSFinal Results
3rd Sep 20197:00 amRNSNotice of Results
19th Aug 20197:00 amRNSHolding(s) in Company
30th Jul 201912:12 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSTrading Statement
13th May 201911:42 amRNSDirector/PDMR Shareholding
26th Apr 201912:34 pmRNSDirector/PDMR Shareholding
27th Feb 201911:06 amRNSDirector/PDMR Shareholding
21st Feb 20197:00 amRNSHalf-year Report
10th Jan 20197:00 amRNSTrading Statement
31st Dec 20187:00 amRNSNotice of Trading Update and Half-Year Results
16th Nov 20183:52 pmRNSDirector/PDMR Shareholding
7th Nov 20184:40 pmRNSSecond Price Monitoring Extn
7th Nov 20184:35 pmRNSPrice Monitoring Extension
7th Nov 20182:05 pmRNSSecond Price Monitoring Extn
7th Nov 20182:00 pmRNSPrice Monitoring Extension
7th Nov 201811:05 amRNSSecond Price Monitoring Extn
7th Nov 201811:00 amRNSPrice Monitoring Extension
7th Nov 201810:41 amRNSResult of Annual General Meeting
7th Nov 20189:05 amRNSSecond Price Monitoring Extn
7th Nov 20189:00 amRNSPrice Monitoring Extension
7th Nov 20187:00 amRNSAnnual General Meeting Statement
6th Nov 201812:35 pmRNSHolding(s) in Company
8th Oct 20184:49 pmRNSNotice of AGM & Posting of Annual Report
25th Sep 201811:00 amRNSPrice Monitoring Extension
21st Sep 201811:00 amRNSHolding(s) in Company
21st Sep 201811:00 amRNSHolding(s) in Company
21st Sep 201811:00 amRNSDirector/PDMR Shareholding
19th Sep 20184:41 pmRNSSecond Price Monitoring Extn
19th Sep 20184:35 pmRNSPrice Monitoring Extension
19th Sep 20187:01 amRNSFinal Results
19th Sep 20187:00 amRNSSkinny Tan to be ranged in Boots UK
12th Sep 20181:57 pmRNSExercise of Warrants
8th Aug 20184:40 pmRNSSecond Price Monitoring Extn
8th Aug 20184:35 pmRNSPrice Monitoring Extension
8th Aug 20187:00 amRNSAppointment of CEO and Roots to be ranged in Tesco
19th Jun 20187:00 amRNSTrading Statement
8th May 20183:35 pmRNSDirector/PDMR Shareholding
8th May 20183:35 pmRNSTR-1
8th May 20183:35 pmRNSTR-1
2nd May 20182:05 pmRNSSecond Price Monitoring Extn
2nd May 20182:00 pmRNSPrice Monitoring Extension
2nd May 201811:05 amRNSSecond Price Monitoring Extn
2nd May 201811:00 amRNSPrice Monitoring Extension
1st May 20184:41 pmRNSSecond Price Monitoring Extn
1st May 20184:35 pmRNSPrice Monitoring Extension
1st May 20183:42 pmRNSLaunch of Prolong in the US and Australia
29th Mar 20184:40 pmRNSSecond Price Monitoring Extn
29th Mar 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.